Prognostic gene expression assays in breast cancer: are two better than one?

por Sparano, Joseph A.
Publicado 2018

Learning from big data: are we undertreating older women with high-risk breast cancer?

por Sparano, Joseph A, Muss, Hyman
Publicado 2016

The ESC Cardio-Oncology Guidelines: A Roadmap for Clinical Practice and Generating Needed Evidence

por Sparano, Joseph A., Sahni, Gagan
Publicado 2022

Progress in adjuvant chemotherapy for breast cancer: an overview

por Anampa, Jesus, Makower, Della, Sparano, Joseph A.
Publicado 2015

The clinical utility of gene expression assays in breast cancer patients with 0–3 involved lymph nodes

por Barbi, Mali, Makower, Della, Sparano, Joseph A.
Publicado 2021

Paradigms and Controversies in the Treatment of HIV-Related Burkitt Lymphoma

por Petrich, Adam M., Sparano, Joseph A., Parekh, Samir
Publicado 2012

An emerging generation of endocrine therapies in breast cancer: a clinical perspective

por Patel, Rima, Klein, Paula, Tiersten, Amy, Sparano, Joseph A.
Publicado 2023

Lymphovascular invasion, race, and the 21-gene recurrence score in early estrogen receptor-positive breast cancer

por Makower, Della, Lin, Juan, Xue, Xiaonan, Sparano, Joseph A.
Publicado 2021

The 21-gene recurrence score in early non-ductal breast cancer: a National Cancer Database analysis

por Makower, Della, Qin, Jiyue, Lin, Juan, Xue, Xiaonan, Sparano, Joseph A.
Publicado 2022

Pooled analysis of AIDS Malignancy Consortium (AMC) trials evaluating rituximab plus either CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin’s lymphoma

por Barta, Stefan K, Lee, Jeannette Y, Sparano, Joseph A, Kaplan, Lawrence D, Noy, Ariela
Publicado 2010

Evaluation of serum Amphiregulin levels in breast cancer patients and cancer-free controls

por Peterson, Esther A, Pectasides, Eirini, Shabbeer, Shabana, Wiechmann, Lisa, Sparano, Joseph A, Kenny, Paraic A
Publicado 2013

The AKT inhibitor triciribine in combination with paclitaxel has order-specific efficacy against Zfp217-induced breast cancer chemoresistance

por Suarez, Christopher D., Wu, Junmin, Badve, Sunil S., Sparano, Joseph A., Kaliney, William, Littlepage, Laurie E.
Publicado 2017

Development and Validation of a Tool Integrating the 21-Gene Recurrence Score and Clinical-Pathological Features to Individualize Prognosis and Prediction of Chemotherapy Benefit i...

por Sparano, Joseph A., Crager, Michael R., Tang, Gong, Gray, Robert J., Stemmer, Salomon M., Shak, Steven
Publicado 2021

The Contribution of Race to Breast Tumor Microenvironment Composition and Disease Progression

por Kim, Gina, Pastoriza, Jessica M., Condeelis, John S., Sparano, Joseph A., Filippou, Panagiota S., Karagiannis, George S., Oktay, Maja H.
Publicado 2020

A pilot safety-feasibility dietary trial targeting insulin inhibition in ten patients with advanced cancer

por Fine, Eugene J, Segal-Isaacson, C, Herzkopf, Silvia, Sparano, Joseph, Romano, Maria, Feinman, Richard, Tomuta, Nora, Bontempo, Amanda
Publicado 2012

Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: a randomized Phase II study comparing the incidence of peripheral neuropathy

por Vahdat, Linda T., Garcia, Agustin A., Vogel, Charles, Pellegrino, Christine, Lindquist, Deborah L., Iannotti, Nicholas, Gopalakrishna, Prashanth, Sparano, Joseph A.
Publicado 2013

Simulation Modeling to Extend Clinical Trials of Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Early Breast Cancer

por Jayasekera, Jinani, Sparano, Joseph A, Gray, Robert, Isaacs, Claudine, Kurian, Allison, O’Neill, Suzanne, Schechter, Clyde B, Mandelblatt, Jeanne
Publicado 2019

Can inhibiting insulin/IGF signaling with dietary carbohydrate restriction play a role in treatment/prevention of cancers?

por Fine, Eugene J, Segal-Isaacson, C, Herzkopf, Silvia, Sparano, Joseph, Romano, Maria, Feinman, Richard, Tomuta, Nora, Bontempo, Amanda, Negassa, Abdissa
Publicado 2014

Comparative clinical benefits of systemic adjuvant therapy for paradigm solid tumors

por Kirkwood, John M., Tarhini, Ahmad, Sparano, Joseph A., Patel, Prapti, Schiller, Joan H., Vergo, Maxwell T., Benson, Al B., Tawbi, Hussein
Publicado 2012

Enriched transcription factor signatures in triple negative breast cancer indicates possible targeted therapies with existing drugs

por Willis, Scooter, De, Pradip, Dey, Nandini, Long, Bradley, Young, Brandon, Sparano, Joseph A., Wang, Victoria, Davidson, Nancy E., Leyland-Jones, Brian R.
Publicado 2015